LEADER 04624nam 2200589Ia 450 001 9910452202503321 005 20200520144314.0 010 $a1-60876-707-8 035 $a(CKB)2550000001041297 035 $a(EBL)3018377 035 $a(SSID)ssj0000835562 035 $a(PQKBManifestationID)12354374 035 $a(PQKBTitleCode)TC0000835562 035 $a(PQKBWorkID)10989961 035 $a(PQKB)11461328 035 $a(MiAaPQ)EBC3018377 035 $a(Au-PeEL)EBL3018377 035 $a(CaPaEBR)ebr10660238 035 $a(OCoLC)844348818 035 $a(EXLCZ)992550000001041297 100 $a20091021d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aImmunosuppression$b[electronic resource] $enew research /$fCharles B. Taylor, editor 210 $aNew York $cNova Science Pub. Inc.$d2009 215 $a1 online resource (320 p.) 300 $aDescription based upon print version of record. 311 $a1-60692-102-9 320 $aIncludes bibliographical references and index. 327 $a""Immunosuppression: New Research""; ""Contents""; ""Preface""; ""Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?""; ""Abstract""; ""Introduction""; ""Costimulation Blockade""; ""Regulatory T-Cells""; ""Conclusion""; ""References""; ""Strategies for T Cell Depletion to Prevent Graft versus Host Disease""; ""Abstract""; ""Introduction""; ""Pharmacological Intervention""; ""T Cell Depletion - An Effective Non-PharmacologicImmunosuppression""; ""Pre a???Clinical Models and Early Clinical Studies""; ""Strategies of T Cell Depletion"" 327 $a""Merits and Problems with TCD""""Haploidentical Transplantation""; ""Strategies to Improve Outcome of Patients with TCell Depletion""; ""Conclusions""; ""References""; ""Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels""; ""Abstract""; ""Introduction""; ""Acute and Chronic Transplant Rejection""; ""Immunosuppression""; ""Conclusion""; ""References""; ""Indications and Management of m-TOR Inhibitors after Liver Transplantation""; ""Abstract""; ""Introduction""; ""Objectives""; ""Material and Methods"" 327 $a""Results""""Discussion""; ""References""; ""Evolution of Immunosuppression in Liver Transplantation""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""Evolution of Immunosuppression""; ""Recent Advances in ImmunosuppressionFollowing Liver Transplantation""; ""Conclusion""; ""References""; ""The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients""; ""Abstract""; ""Introduction""; ""Current Immunosuppressive Drugs""; ""Pharmacogenomics and Drug Metabolism""; ""Genetic Polymorphism and Immunosuppressive Drugs"" 327 $a""Limitations of Clinical application of Pharmacogenomics""""Conclusion""; ""References""; ""Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts""; ""Abstract""; ""Introduction""; ""Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation""; ""Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts""; ""POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood""; ""Conclusion""; ""References"" 327 $a""Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells""""Abstract""; ""Introduction""; ""Immunosuppression Only Requires Exposure toLow Doses of UV Radiation""; ""Sunlight Is Immunosuppressive""; ""UV-Induced Regulatory Cells""; ""Factors Involved in the Activationof UV-Regulatory Cells""; ""Dendritic Cells as Mediators of Regulatory T Cell Activation""; ""Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues""; ""Regulatory B Cells as Facilitatorsof UV-Immunosuppression""; ""Conclusion""; ""References"" 327 $a""Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation"" 606 $aImmunosuppression 606 $aImmunosuppressive agents 608 $aElectronic books. 615 0$aImmunosuppression. 615 0$aImmunosuppressive agents. 676 $a615.37 701 $aTaylor$b Charles B$0971007 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910452202503321 996 $aImmunosuppression$92206961 997 $aUNINA